DIVIDEND ANNOUNCEMENT: Lilly (Eli) & Co (NYSE:LLY) on 06/22/2026 declared a dividend of $1.7300 per share

Lilly (Eli) & Co (NYSE:LLY) on 06/22/2026 declared a dividend of $ 1.7300 per share payable on September 10, 2026 to shareholders of record as of August 14, 2026.

Lilly (Eli) & Co (NYSE:LLY) has paid dividends since 1885, has a current dividend yield of 0.6299098134% and has increased its dividends for 11 successive years.

Lilly (Eli) & Co's market cap is $ 1,034,568,410,370 and has a PE ratio of 39.03. The stock price closed yesterday at $ 1098.57 and has a 52 week low/high of $ 623.78 and $ 1182.73.

Eli Lilly and Co. is a medicine company. Co. discovers, develops, manufactures and markets products in the human pharmaceutical products segment. Its diabetes, obesity and other cardiometabolic products include Basaglar, Humalog, Mounjaro, Trulicity and Zepbound. Its oncology products include Alimta, Retevmo, Tyvyt and Verzenio. Its immunology products include Ebglyss, Olumiant, Omvoh and Taltz. Its neuroscience products include Cymbalta and Emgality. Its other products and therapies include Cialis and Forteo. It manufactures and distributes its products through facilities in the U.S. (U.S.), including Puerto Rico, and in Europe and Asia.

For more information on Lilly (Eli) & Co click here.